We serve Chemical Name:2,7-diazaspiro[3.5]nonane CAS:136098-14-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2,7-diazaspiro[3.5]nonane](https://a.dearchem.com/CAS2/136098-14-1.png)
Chemical Name:2,7-diazaspiro[3.5]nonane
CAS.NO:136098-14-1
Synonyms:2,7-Diazaspiro[3.5]nonane hydrochloride (1:1);2,7-Diazaspiro[3.5]nonane, hydrochloride (1:1)
Molecular Formula:C7H15ClN2
Molecular Weight:162.660
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:415.714ºC at 760 mmHg
Density:1.159g/cm3
Index of Refraction:1.601
PSA:24.06000
Exact Mass:162.092377
LogP:0.61700
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2,7-Diazaspiro[3.5]nonane hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,7-Diazaspiro[3.5]nonane, hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,7-Diazaspiro[3.5]nonane hydrochloride (1:1) Use and application,2,7-Diazaspiro[3.5]nonane, hydrochloride (1:1) technical grade,usp/ep/jp grade.
Related News: EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML). methyl N-[(2R)-2-(3,5-difluorophenyl)-2-hydroxylacetyl]-L-alaninate manufacturers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. N1-{[4-(4,5-Dihydrobenzo[2,3]thiepino[4,5-d][1,3]thiazol-2-ylamino)cyclohexyl]methyl}-3-(trifluoromethyl)-1-benzenesulfonamide suppliers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. Oxidase, cytochrome (Blackburnia kilauea mitochondria-encodedclone JK144 gene COII subunit II fragment) vendor & factory.
